Indication

Anthrax septicemia

Anthrax septicemia is a life-threatening, systemic manifestation of anthrax resulting from the hematogenous dissemination and proliferation of *Bacillus anthracis* bacteremia. Read more about Anthrax septicemia

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Anthrax septicemia therapies.

Showing 1–9 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Anthrax septicemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anthrax septicemia.

Anthrax septicemia is a life-threatening, systemic manifestation of anthrax resulting from the hematogenous dissemination and proliferation of *Bacillus anthracis* bacteremia.

It can arise as a severe complication from any primary portal of entry—including cutaneous, inhalational, gastrointestinal, or injectional forms—and affects the cardiovascular and multi-organ systems across pediatric and adult populations.

Pathophysiologically, widespread bacterial multiplication is accompanied by the heavy release of anthrax exotoxins (lethal toxin and edema toxin), precipitating profound vascular permeability, extensive tissue edema, coagulopathy, septic shock, and multi-organ failure.

Personalize your experience

Follow Anthrax septicemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it